The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 772K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

8 articles for Y Bu


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
10
Design, synthesis and biological evaluation of novel 4-arylaminopyrimidine derivatives possessing a hydrazone moiety as dual inhibitors of L1196M ALK and ROS1.EBI
Shenyang Pharmaceutical University
29
Design and biological evaluation of novel 4-(2-fluorophenoxy)quinoline derivatives bearing an imidazolone moiety as c-Met kinase inhibitors.EBI
Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University)
22
Syntheses of novel high affinity ligands for opioid receptors.EBI
Rensselaer Polytechnic Institute
41
Syntheses and opioid receptor binding properties of carboxamido-substituted opioids.EBI
Rensselaer Polytechnic Institute
6
Synthesis and opioid receptor binding properties of a highly potent 4-hydroxy analogue of naltrexone.EBI
Rensselaer Polytechnic Institute
23
Discovery and Characterization of Potent Dual P-Glycoprotein and CYP3A4 Inhibitors: Design, Synthesis, Cryo-EM Analysis, and Biological Evaluations.EBI
Athenex
9
Discovery of Novel Dual Mechanism of Action Src Signaling and Tubulin Polymerization Inhibitors (KX2-391 and KX2-361).EBI
Athenex
39
Substituted carbazole compoundsBDB
Bristol Myers Squibb